JOHNSON JOHN 4/A SEC Filings

Filed On	Filing
20 Dec 2022	Form 4/A: Johnson John, Director · Verastem Inc Granted 62,500 Stock Option (right to buy)
08 Oct 2021	Form 4/A: Johnson John, Director · Xeris Biopharma Holdings, Inc. Received 478,312 shares as a grant or award · Granted 408,297 Stock Option (Right to Buy)
24 Sep 2012	Form 4/A: Johnson John, Director · DENDREON CORP Received 335,215 shares as a grant or award · Granted 667,608 Non-Qualified Stock Option (right to buy) ($9.46M)

Comments